Essential role for p38α MAPK but not p38γ MAPK in Igf2 expression and myoblast differentiation

Endocrinology

Volumn 151, Issue 9, 2010, Pages 4368-4380

  Lovett, Fiona A ^a   Cosgrove, Ruth A ^a   Gonzalez, Ivelisse ^a   Pell, Jennifer M ^a  

^a BABRAHAM INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; ISOENZYME; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 12; MITOGEN ACTIVATED PROTEIN KINASE 14; MYOGENIN; MYOSIN HEAVY CHAIN; PROTEIN KINASE B; SHORT HAIRPIN RNA; SOMATOMEDIN B; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ENZYME INHIBITOR; IMIDAZOLE DERIVATIVE; LUCIFERASE; PYRIDINE DERIVATIVE;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; MOUSE; MUSCLE DEVELOPMENT; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SATELLITE CELL; ANIMAL; CELL CULTURE; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENETIC TRANSFECTION; GENETICS; METABOLISM; NORTHERN BLOTTING; PHYSIOLOGY; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE SATELLITE CELL; WESTERN BLOTTING;

ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CASPASE 3; CELL DIFFERENTIATION; CELLS, CULTURED; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; GENE KNOCKOUT TECHNIQUES; IMIDAZOLES; INSULIN-LIKE GROWTH FACTOR II; LUCIFERASES; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 12; MITOGEN-ACTIVATED PROTEIN KINASE 14; MYOGENIN; MYOSIN HEAVY CHAINS; PROMOTER REGIONS, GENETIC; PYRIDINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SATELLITE CELLS, SKELETAL MUSCLE; TRANSFECTION;

EID: 77956023089     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-0209     Document Type: Article

References (54)

1. Sacco A, Doyonnas R, Kraft P, Vitorovic S, Blau HM 2008 Self-renewal and expansion of single transplanted muscle stem cells. Nature 456:502-506
2. Holterman CE, Rudnicki MA 2005 Molecular regulation of satellite cell function. Semin Cell Dev Biol 16:575-584
3. Shefer G, Van de Mark DP, Richardson JB, Yablonka-Reuveni Z 2006 Satellite-cell pool size does matter: defining the myogenic potency of aging skeletal muscle. Dev Biol 294:50-66
4. Florini JR, Ewton DZ, Coolican SA 1996 Growth hormone and the insulin-like growth factor system in myogenesis. Endocr Rev 17:481-517 (Pubitemid 26346639)
5. Nakae J, Kido Y, Accili D 2001 Distinct and overlapping functions of insulin and IGF-I receptors. Endocr Rev 22:818-835
6. Bondy CA, Werner H, Roberts Jr CT, LeRoith D 1990 Cellular pattern of insulin-like growth factor-I (IGF-I) and type I IGF receptor gene expression in early organogenesis: comparison with IGF-II gene expression. Mol Endocrinol 4:1386-1398
7. DeChiara TM, Efstratiadis A, Robertson EJ 1990 A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 345:78-80 (Pubitemid 20152456)
8. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A 1993 Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75:59-72
9. Tiffin N, Adi S, Stokoe D, Wu NY, Rosenthal SM 2004 Akt phosphorylation is not sufficient for insulin-like growth factor-stimulated myogenin expression but must be accompanied by down-regulation of mitogen-activated protein kinase/extracellular signal-regulated kinase phosphorylation. Endocrinology 145:4991-4996
10. Wilson EM, Rotwein P 2006 Control of MyoD function during initiation of muscle differentiation by an autocrine signaling pathway activated by insulin-like growth factor-II. J Biol Chem 281:29962-29971
11. Gonzalez I, Tripathi G, Carter EJ, Cobb LJ, Salih DA, Lovett FA, Holding C, Pell JM 2004 Akt2, a novel functional link between p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways in myogenesis. Mol Cell Biol 24:3607-3622
12. Tureckova J, Wilson EM, Cappalonga JL, Rotwein P 2001 Insulin-like growth factor-mediated muscle differentiation: collaboration between phosphatidylinositol 3-kinase-Akt-signaling pathways and myogenin. J Biol Chem 276:39264-39270
13. Wu Z, Woodring PJ, Bhakta KS, Tamura K, Wen F, Feramisco JR, Karin M, Wang JY, Puri PL 2000 p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps. Mol Cell Biol 20:3951-3964
14. Zhao M, New L, Kravchenko VV, Kato Y, Gram H, di Padova F, Olson EN, Ulevitch RJ, Han J 1999 Regulation of the MEF2 family of transcription factors by p38. Mol Cell Biol 19:21-30
15. Lluís F, Ballestar E, Suelves M, Esteller M, Muñoz- Cánoves P 2005 E47 phosphorylation by p38 MAPK promotes MyoD/E47 association and muscle-specific gene transcription. EMBO J 24:974-984 (Pubitemid 40470146)
16. Briata P, Forcales SV, Ponassi M, Corte G, Chen CY, Karin M, Puri PL, Gherzi R 2005 p38-dependent phosphorylation of the mRNA decay-promoting factor KSRP controls the stability of select myogenic transcripts. Mol Cell 20:891-903
17. Simone C, Forcales SV, Hill DA, Imbalzano AN, Latella L, Puri PL 2004 p38 pathway targets SWI-SNF chromatin-remodeling complex to muscle-specific loci. Nat Genet 36:738-743
18. Lovett FA, Gonzalez I, Salih DA, Cobb LJ, Tripathi G, Cosgrove RA, Murrell A, Kilshaw PJ, Pell JM 2006 Convergence of Igf2 expression and adhesion signalling via RhoA and p38 MAPK enhances myogenic differentiation. J Cell Sci 119:4828-4840
19. Bae GU, Kim BG, Lee HJ, Oh JE, Lee SJ, Zhang W, Krauss RS, Kang JS 2009 Cdo binds Abl to promote p38α/β mitogen-activated protein kinase activity and myogenic differentiation. Mol Cell Biol 29:4130-4143
20. Tortorella LL, Lin CB, Pilch PF 2003 ERK6 is expressed in a developmentally regulated manner in rodent skeletal muscle. Biochem Biophys Res Commun 306:163-168
21. Ventura JJ, Tenbaum S, Perdiguero E, Huth M, Guerra C, Barbacid M, Pasparakis M, Nebreda AR 2007 p38α MAP kinase is essential in lung stem and progenitor cell proliferation and differentiation. Nat Genet 39:750-758
22. Ruiz-Bonilla V, Perdiguero E, Gresh L, Serrano AL, Zamora M, Sousa-Victor P, Jardí M, Wagner EF, Muñoz-Cánoves P 2008 Efficient adult skeletal muscle regeneration in mice deficient in p38β, p38γ and p38δ MAP kinases. Cell Cycle 7:2208-2214
23. Gillespie MA, Le Grand F, Scimè A, Kuang S, von Maltzahn J, Seale V, Cuenda A, Ranish JA, Rudnicki MA 2009 p38-γ-dependent gene silencing restricts entry into the myogenic differentiation program. J Cell Biol 187:991-1005
24. Stewart CE, Rotwein P 1996 Insulin-like growth factor-II is an autocrine survival factor for differentiating myoblasts. J Biol Chem 271:11330-11338 (Pubitemid 26155970)
25. Carter EJ, Cosgrove RA, Gonzalez I, Eisemann JH, Lovett FA, Cobb LJ, Pell JM 2009 MEK5 and ERK5 are mediators of the pro-myogenic actions of IGF-2. J Cell Sci 122:3104-3112
26. Héron-Milhavet L, Karas M, Goldsmith CM, Baum BJ, LeRoith D 2001 Insulin-like growth factor-I (IGF-I) receptor activation rescues UV-damaged cells through a p38 signaling pathway. Potential role of the IGF-I receptor in DNA repair. J Biol Chem 276:18185-18192
27. Kaneko S, Feldman RI, Yu L, Wu Z, Gritsko T, Shelley SA, Nicosia SV, Nobori T, Cheng JQ 2002 Positive feedback regulation between Akt2 and MyoD during muscle differentiation. Cloning of Akt2 promoter. J Biol Chem 277:23230-23235
28. Cobb LJ, Salih DA, Gonzalez I, Tripathi G, Carter EJ, Lovett F, Holding C, Pell JM 2004 Partitioning of IGFBP-5 actions in myogenesis: IGF-independent anti-apoptotic function. J Cell Sci 117:1737-1746
29. Van Laere AS, Nguyen M, Braunschweig M, Nezer C, Collette C, Moreau L, Archibald AL, Haley CS, Buys N, Tally M, Andersson G, Georges M, Andersson L 2003 A regulatory mutation in IGF2 causes a major QTL effect on muscle growth in the pig. Nature 425:832-836
30. Tollefsen SE, Lajara R, McCusker RH, Clemmons DR, Rotwein P 1989 Insulin-like growth factors (IGF) in muscle development. Expression of IGF-I, the IGF-I receptor, and an IGF binding protein during myoblast differentiation. J Biol Chem 264:13810-13817
31. Ge Y, Wu AL, Warnes C, Liu J, Zhang C, Kawasome H, Terada N, Boppart MD, Schoenherr CJ, Chen J 2009 mTOR regulates skeletal muscle regeneration in vivo through kinase-dependent and kinase-independent mechanisms. Am J Physiol Cell Physiol 297:C1434-C1444
32. Kamochi H, Kurokawa MS, Yoshikawa H, Ueda Y, Masuda C, Takada E, Watanabe K, Sakakibara M, Natuki Y, Kimura K, Beppu M, Aoki H, Suzuki N 2006 Transplantation of myocyte precursors derived from embryonic stem cells transfected with IGFII gene in a mouse model of muscle injury. Transplantation 82:516-526
33. Clemmons DR 2009 Role of IGF-I in skeletal muscle mass maintenance. Trends Endocrinol Metab 20:349-356
34. Adams RH, Porras A, Alonso G, Jones M, Vintersten K, Panelli S, Valladares A, Perez L, Klein R, Nebreda AR 2000 Essential role of p38α MAP kinase in placental but not embryonic cardiovascular development. Mol Cell 6:109-116
35. Allen M, Svensson L, Roach M, Hambor J, McNeish J, Gabel CA 2000 Deficiency of the stress kinase p38α results in embryonic lethality: characterization of the kinase dependence of stress responses of enzyme-deficient embryonic stem cells. J Exp Med 191:859-870
36. Mudgett JS, Ding J, Guh-Siesel L, Chartrain NA, Yang L, Gopal S, Shen MM 2000 Essential role for p38α mitogen-activated protein kinase in placental angiogenesis. Proc Natl Acad Sci USA 97:10454-10459
37. Tamura K, Sudo T, Senftleben U, Dadak AM, Johnson R, Karin M 2000 Requirement for p38α in erythropoietin expression: a role for stress kinases in erythropoiesis. Cell 102:221-231
38. Perdiguero E, Ruiz-Bonilla V, Gresh L, Hui L, Ballestar E, Sousa-Victor P, Baeza-Raja B, Jardi M, Bosch-Comas A, Esteller M, Caelles C, Serrano AL, Wagner EF, Muñoz-Cánoves P 2007 Genetic analysis of p38 MAP kinases in myogenesis: fundamental role of p38α in abrogating myoblast proliferation. EMBO J 26:1245-1256
39. Lechner C, Zahalka MA, Giot JF, Møller NP, Ullrich A 1996 ERK6, a mitogen-activated protein kinase involved in C2C12 myoblast differentiation. Proc Natl Acad Sci USA 93:4355-4359 (Pubitemid 26144291)
40. Sabio G, Arthur JS, Kuma Y, Peggie M, Carr J, Murray-Tait V, Centeno F, Goedert M, Morrice NA, Cuenda A 2005 p38γ regulates the localisation of SAP97 in the cytoskeleton by modulating its interaction with GKAP. EMBO J 24:1134-1145
41. Perdiguero E, Sousa-Victor P, Ballestar E, Muñoz-Cánoves P 2009 Epigenetic regulation of myogenesis. Epigenetics 4:541-550
42. Wang H, Xu Q, Xiao F, Jiang Y, Wu Z 2008 Involvement of the p38 mitogen-activated protein kinase α, β, and γ isoforms in myogenic differentiation. Mol Biol Cell 19:1519-1528
43. Ho RC, Alcazar O, Fujii N, Hirshman MF, Goodyear LJ 2004 p38γ MAPK regulation of glucose transporter expression and glucose uptake in L6 myotubes and mouse skeletal muscle. Am J Physiol Regul Integr Comp Physiol 286:R342-R349
44. Pogozelski AR, Geng T, Li P, Yin X, Lira VA, Zhang M, Chi JT, Yan Z 2009 p38γ mitogen-activated protein kinase is a key regulator in skeletal muscle metabolic adaptation in mice. PLoS One 4:e7934
45. de Angelis L, Zhao J, Andreucci JJ, Olson EN, Cossu G, McDermott JC 2005 Regulation of vertebrate myotome development by the p38 MAP kinase-MEF2 signaling pathway. Dev Biol 283:171-179
46. Bergstrom DA, Penn BH, Strand A, Perry RL, Rudnicki MA, Tapscott SJ 2002 Promoter-specific regulation of MyoD binding and signal transduction cooperate to pattern gene expression. Mol Cell 9:587-600
47. Penn BH, Bergstrom DA, Dilworth FJ, Bengal E, Tapscott SJ 2004 A MyoD-generated feed-forward circuit temporally patterns gene expression during skeletal muscle differentiation. Genes Dev 18:2348-2353 (Pubitemid 39304681)
48. Rampalli S, Li L, Mak E, Ge K, Brand M, Tapscott SJ, Dilworth FJ 2007 p38 MAPK signaling regulates recruitment of Ash2L-containing methyltransferase complexes to specific genes during differentiation. Nat Struct Mol Biol 14:1150-1156
49. Jemth P, Gianni S 2007 PDZ domains: folding and binding. Biochemistry 46:8701-8708
50. Hasegawa M, Cuenda A, Spillantini MG, Thomas GM, Buée-Scherrer V, Cohen P, Goedert M 1999 Stress-activated protein kinase-3 interacts with the PDZ domain of α1-syntrophin. A mechanism for specific substrate recognition. J Biol Chem 274:12626-12631
51. Feron M, Guevel L, Rouger K, Dubreil L, Arnaud MC, Ledevin M, Megeney LA, Cherel Y, Sakanyan V 2009 PTEN contributes to profound PI3K/Akt signaling pathway deregulation in dystrophin-deficient dog muscle. Am J Pathol 174:1459-1470
52. Seta K, Sadoshima J 2002 What is the unique function of SAPK3/p38γ in cardiac myocytes? J Mol Cell Cardiol 34:597-600
53. Yang SH, Galanis A, Sharrocks AD 1999 Targeting of p38 mitogen-activated protein kinases to MEF2 transcription factors. Mol Cell Biol 19:4028-4038 (Pubitemid 29241977)
54. Cuenda A, Cohen P, Buée-Scherrer V, Goedert M 1997 Activation of stress-activated protein kinase-3 (SAPK3) by cytokines and cellular stresses is mediated via SAPKK3 (MKK6); comparison of the specificities of SAPK3 and SAPK2 (RK/p38). EMBO J 16:295-305